---
title: "ELAN: Q2 2026 delivered double-digit revenue growth, margin expansion, and raised full-year guidance"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294950665.md"
description: "Q2 2026 saw 10% revenue growth and 21% higher adjusted EBITDA, led by blockbuster products and strong U.S. segment performance. Full-year guidance was raised across revenue, EBITDA, and EPS, with improved leverage and continued innovation investment.Original document: Elanco Animal Health Incorporated [ELAN] SEC 8-K Current Report — Aug. 5 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-08-05T10:37:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294950665.md)
  - [en](https://longbridge.com/en/news/294950665.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294950665.md)
generator: "portal-rs"
---

# ELAN: Q2 2026 delivered double-digit revenue growth, margin expansion, and raised full-year guidance

Q2 2026 saw 10% revenue growth and 21% higher adjusted EBITDA, led by blockbuster products and strong U.S. segment performance. Full-year guidance was raised across revenue, EBITDA, and EPS, with improved leverage and continued innovation investment.

Original document: Elanco Animal Health Incorporated \[ELAN\] SEC 8-K Current Report — Aug. 5 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [ELAN.US](https://longbridge.com/en/quote/ELAN.US.md)

## Related News & Research

- [Elanco Animal Health (ELAN) Lifted Guidance, Is The 21% Discount Still There?](https://longbridge.com/en/news/296298826.md)
- [Top Executive Quietly Boosts Stake in Elanco Animal Health](https://longbridge.com/en/news/296293784.md)
- [BEWI: Q2 2026 delivered double-digit sales and EBITDA growth, with strong performance across all segments](https://longbridge.com/en/news/296303987.md)
- [INVEST: Revenue and profit dropped sharply in H1 2026, with 2026 outlook remaining subdued](https://longbridge.com/en/news/296439091.md)
- [Elanco director Lawrence Kurzius acquires 40,000 common shares for $935,920](https://longbridge.com/en/news/296649591.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**